News tagged with b cell lymphoma
More intensive chemotherapy dramatically improves recurrence, survival in younger patients with aggressive lymphoma
Younger patients with diffuse large B-cell lymphoma given a more intensive regimen of chemotherapy combined with rituximab survive significantly longer, and are approximately twice as likely to remain in remission 3 years ...
Nov 24, 2011 |
not rated yet |
0
A better target for B-cell lymphomas: From a library of MAG antagonists to nanomolar CD22 ligands
Patients suffering from B-cell lymphomas can be treated with antibodies directed against the B-lymphocyte antigen CD20.
Oct 25, 2011 |
not rated yet |
0
|
Targeting the Ewing sarcoma family of tumors
The Max Cure Foundation and the Samuel Waxman Cancer Research Foundation have partnered to establish a fund in pediatric cancer research. With that goal in mind, the two Foundations are proud to announce the award of $100,000 ...
Jul 01, 2011 |
not rated yet |
0
New research provides breakthrough in understanding common cancer
Researchers from the University of Sheffield have discovered valuable insight into how people develop B-cell lymphoma, one of the most common cancers in the UK.
Jun 09, 2011 |
1 / 5 (1) |
0
|
Study reveals how fusion protein triggers cancer
What happens when two proteins join together? In this case, they become like a power couple, where the whole is greater than the sum of the parts.
Jan 27, 2011 |
4.3 / 5 (3) |
1
|
Patent awarded for method to dampen immune response
National Jewish Health has been issued a US patent claiming a method to desensitize B cells by inactivating antigen receptors on their surfaces. The method, discovered by John Cambier, PhD, Chairman of the Integrated Department ...
Jan 18, 2011 |
not rated yet |
1
Scientists identify possible gene target for treating a form of lymphoma
Researchers have identified a mutation in a gene that could lead to targeted therapies for certain lymphoma patients whose cure rates are currently poor. Mutation of the MYD88 gene was found to be one of the most frequent ...
Dec 22, 2010 |
not rated yet |
0
New mutation linked to non-Hodgkin's lymphoma
Some patients with non-Hodgkin lymphoma (NHL) -- a cancer of B cells -- harbor a particular mutation in the gene encoding the receptor for B cell activating factor (BAFF), according to a paper published online on November ...
Nov 01, 2010 |
not rated yet |
0
Scientists find new way to attack cancerous cells
Scripps Research Institute scientists have discovered a new way to target and destroy a type of cancerous cell. The findings may lead to the development of new therapies to treat lymphomas, leukemias, and related cancers.
Jun 07, 2010 |
5 / 5 (11) |
0
|
Small molecule targets B cell lymphoma
Scientists are one step closer to developing a targeted therapy for lymphoma. New research, published by Cell Press in the April 13th issue of the journal Cancer Cell, identifies a specific small-molecule inhibitor that w ...
Apr 12, 2010 |
5 / 5 (2) |
0
Scientists announce advance in understanding body's natural defenses
Medical Research Council (MRC) scientists at the University of Leicester have made a new advance in understanding how the body fights certain types of cancer and other disease such as Lupus and rheumatoid arthritis.
Mar 11, 2010 |
not rated yet |
0
What is the function of the protein CD20?
Antibodies directed against the protein CD20, which is expressed by immune cells known as B cells, are used to treat B cell non-Hodgkin lymphoma and rheumatoid arthritis. Despite this, the function of CD20 has not been determined. ...
Dec 22, 2009 |
not rated yet |
0
A new target for lymphoma therapy
Researchers at the Program in Cellular and Molecular Medicine and the Immune Disease Institute at Children's Hospital Boston (PCMM/IDI) have found a link between a common mutation that can lead to cancer and ...
Dec 09, 2009 |
not rated yet |
0
Microsoft co-founder Allen treated for lymphoma
(AP) -- Microsoft Corp. co-founder and billionaire investor Paul Allen has been diagnosed with non-Hodgkin's lymphoma and is undergoing chemotherapy.
Nov 17, 2009 |
not rated yet |
0
Researchers find new way to attack inflammation in Graves' eye disease
A small group of patients with severe Graves' eye disease experienced rapid improvement of their symptoms — and improved vision — following treatment with the drug rituximab. Inflammation around their eyes and damage to the ...
Nov 06, 2009 |
not rated yet |
0
